CAS 112193-75-6

2,2'-(1,4,7,10-Tetraazacyclododecane-1,7-diyl)diacetic acid

CAS : 112193-75-6

2,2'-(1,4,7,10-Tetraazacyclododecane-1,7-diyl)diacetic acid

Degré de pureté : 98%

Masse moléculaire : 288.35g/mol

Ref: 54-OR1061555

Gadoteridol Impurity 15 4HCl (DO2A 4HCl)

CAS : 112193-75-6

Formule : C₁₂H₂₄N₄O₄·4HCl

Couleur et forme : White To Off-White Solid

Masse moléculaire : 288.35 4 36.46

Ref: 4Z-G-312

1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid

CAS : 112193-75-6

1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid (DOTA) is a chelating agent that forms stable complexes with a range of metal ions. It is used as a radiotracer for positron emission tomography (PET) and single photon emission computed tomography (SPECT). DOTA has been shown to accumulate in cancer tissues and organs due to its high molecular weight. DOTA has also been used as an anti-inflammatory compound and it has been found to inhibit the release of pro-inflammatory cytokines. Radiolabelled DOTA is commonly used in nuclear medicine diagnostic imaging procedures because it has high uptake in many cancers, including prostate cancer. The reaction mechanism of DOTA involves the formation of an acid from carboxylates. DOTA is metabolized by mammalian cells and can be excreted through urine or bile.

Formule : C₁₂H₂₄N₄O₄

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 288.34 g/mol

Ref: 3D-MEA19375

1,4,7,10-Tetraazacyclododecane-1,7-diacetic Acid Tetrahydrochloride

Produit contrôlé

CAS : 112193-75-6

Formule : C₁₂H₂₄N₄O₄•4HCl

Couleur et forme : Neat

Masse moléculaire : 288.34 + 4(36.46)

Ref: TR-T284925